ATARA BIOTHERAPEUTICS INC (ATRA) Stock Earnings & Estimates
USA - NASDAQ:ATRA - US0465132068 - Common Stock
14.08 USD
-0.18 (-1.26%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 63.57M 212.54% | 8.573M -86.51% | 128.94M 1,404.02% | 121.39M -5.86% | 53.977M -55.53% | 4.743M -91.21% | 83.595M 1,662.49% | 156.56M 87.28% | 228.9M 46.21% | 96.9M -57.67% | 91.8M -5.26% | |
| EBITDA YoY % growth | -268.9M 18.79% | -264.447M 1.66% | -73.28M 72.29% | 27.948M 138.14% | -12.342M -144.16% | -44.574M -261.16% | -139.74M -213.50% | -120.36M 13.87% | 12.24M 110.17% | 88.74M 625.00% | 134.64M 51.72% | |
| EBIT YoY % growth | -274.55M 19.36% | -269.276M 1.92% | -78.331M 70.91% | -11.245M 85.64% | -7.524M 33.09% | -39.023M -418.67% | 10.064M 125.79% | 70.345M 598.98% | 135.82M 93.08% | 34.68M -74.47% | 30.6M -11.76% | |
| Operating Margin | -431.89% | -3,140.98% | -60.75% | -9.26% | -13.94% | -822.76% | 12.04% | 44.93% | 59.34% | 35.79% | 33.33% | |
| EPS YoY % growth | -68.00 25.07% | -65.50 3.68% | -12.97 80.20% | -1.08 91.70% | -1.09 -1.58% | -3.04 -177.50% | 0.81 126.76% | 4.69 476.97% | 8.40 79.11% | 2.59 -69.15% | 2.23 -13.78% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.88 70.06% | -0.75 36.86% | 2.03 -42.01% | -0.80 -518.74% |
| Revenue Q2Q % growth | 1.426M -96.45% | 1.933M -94.10% | 43.601M -55.58% | 1.885M -89.27% |
| EBITDA Q2Q % growth | -9.486M 46.73% | -6.732M 5.87% | 24.888M -54.34% | -11.934M -276.77% |
| EBIT Q2Q % growth | -11.662M 46.40% | -10.128M 17.00% | 25.905M -50.86% | -9.965M -311.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.19 106.13% | -0.47 | 0.66 | 140.49% |
| Q1 2025 Q2Q % growth | 3.50 160.87% | -2.02 | 5.52 | 273.33% |
| Q4 2024 Q2Q % growth | -1.19 91.50% | -3.65 | 2.46 | 67.38% |
| Q3 2024 Q2Q % growth | -2.93 82.24% | -1.97 | -0.96 | -48.64% |
| Q2 2024 Q2Q % growth | -3.10 81.76% | -1.59 | -1.51 | -94.51% |
| Q1 2024 Q2Q % growth | -5.75 68.06% | -6.54 | 0.79 | 12.03% |
| Q4 2023 Q2Q % growth | -14.00 22.22% | -12.29 | -1.71 | -13.90% |
| Q3 2023 Q2Q % growth | -16.50 19.51% | -16.88 | 0.38 | 2.26% |
| Q2 2023 Q2Q % growth | -17.00 -119.35% | -17.15 | 0.15 | 0.85% |
| Q1 2023 Q2Q % growth | -18.00 17.24% | -9.99 | -8.01 | -80.21% |
| Q4 2022 Q2Q % growth | -18.00 25.00% | -12.95 | -5.05 | -39.04% |
| Q3 2022 Q2Q % growth | -20.50 8.89% | -20.02 | -0.48 | -2.41% |
| Q2 2022 Q2Q % growth | -7.75 65.93% | -23.61 | 15.86 | 67.18% |
| Q1 2022 Q2Q % growth | -21.75 -1.16% | -24.99 | 3.24 | 12.98% |
| Q4 2021 Q2Q % growth | -24.00 -1.05% | -17.48 | -6.52 | -37.30% |
| Q3 2021 Q2Q % growth | -22.50 2.17% | -23.90 | 1.40 | 5.85% |
| Q2 2021 Q2Q % growth | -22.75 20.18% | -22.74 | -0.01 | -0.05% |
| Q1 2021 Q2Q % growth | -21.50 28.33% | -23.47 | 1.97 | 8.39% |
| Q4 2020 Q2Q % growth | -23.75 30.15% | -18.98 | -4.77 | -25.13% |
| Q3 2020 Q2Q % growth | -23.00 29.77% | -27.71 | 4.71 | 17.01% |
| Q2 2020 Q2Q % growth | -28.50 28.75% | -30.16 | 1.66 | 5.50% |
| Q1 2020 Q2Q % growth | -30.00 16.67% | -36.07 | 6.07 | 16.82% |
| Q4 2019 Q2Q % growth | -34.00 | -34.17 | 0.17 | 0.50% |
| Q3 2019 Q2Q % growth | -32.75 | -36.76 | 4.01 | 10.90% |
| Q2 2019 Q2Q % growth | -40.00 | -38.15 | -1.85 | -4.85% |
| Q1 2019 Q2Q % growth | -36.00 | -38.61 | 2.61 | 6.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 17.575M -38.63% | 7.497M | 10.078M | 134.43% |
| Q1 2025 Q2Q % growth | 98.149M 258.77% | 5.78M | 92.369M | 1,598.08% |
| Q4 2024 Q2Q % growth | 32.753M 670.30% | 19.531M | 13.222M | 67.70% |
| Q3 2024 Q2Q % growth | 40.19M 1,779.79% | 35.871M | 4.319M | 12.04% |
| Q2 2024 Q2Q % growth | 28.64M 2,892.69% | 40.79M | -12.15M | -29.79% |
| Q1 2024 Q2Q % growth | 27.357M 2,131.40% | 25.184M | 2.173M | 8.63% |
| Q4 2023 Q2Q % growth | 4.252M 1,832.73% | 11.783M | -7.531M | -63.91% |
| Q3 2023 Q2Q % growth | 2.138M -52.06% | 4.853M | -2.715M | -55.94% |
| Q2 2023 Q2Q % growth | 957K -98.14% | 3.843M | -2.886M | -75.10% |
| Q1 2023 Q2Q % growth | 1.226M -83.23% | 31.291M | -30.065M | -96.08% |
| Q4 2022 Q2Q % growth | 220K -97.09% | 40.466M | -40.246M | -99.46% |
| Q3 2022 Q2Q % growth | 4.46M -16.95% | 5.381M | -921K | -17.12% |
| Q2 2022 Q2Q % growth | 51.58M 1,232.82% | 6.974M | 44.606M | 639.60% |
| Q1 2022 Q2Q % growth | 7.31M 105.92% | 5.011M | 2.299M | 45.88% |
| Q4 2021 Q2Q % growth | 7.55M | 35.846M | -28.296M | -78.94% |
| Q3 2021 Q2Q % growth | 5.37M | 4M | 1.37M | 34.25% |
| Q2 2021 Q2Q % growth | 3.87M | 3.918M | -48K | -1.23% |
| Q1 2021 Q2Q % growth | 3.55M | 1.629M | 1.921M | 117.93% |
| Q4 2020 Q2Q % growth | 13.6M | -13.6M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.35% | 32.97% | 0% | 78.97% |
| Revenue | -3.58% | -76.03% | 0.25% | 246.63% |